Effect of hydrophilic natural gums in formulation of oral-controlled release matrix tablets of propranolol hydrochloride

Pakistan Journal of Pharmaceutical Sciences

Volumn 22, Issue 2, 2009, Pages 211-219

  Rajesh, K S ^a   Venkataraju, M P ^a   Gowda, D V ^b  

^a Parul Institute of Pharmacy and Research   (India)

^b JSS COLLEGE OF PHARMACY   (India)

Author keywords

Controlled release; Locust bean gum; Propranolol hydrochloride; Xanthan gum

Indexed keywords

ALGAROBA; BIOPOLYMER; MAGNESIUM STEARATE; PROPRANOLOL; TALC; XANTHAN; BACTERIAL POLYSACCHARIDE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DRUG CARRIER; GALACTAN; MANNAN; PLANT GUM; STEARIC ACID; STEARIC ACID DERIVATIVE;

ARTICLE; CONTROLLED DRUG RELEASE; CONTROLLED RELEASE FORMULATION; FLOW KINETICS; HYDROPHILICITY; INFRARED SPECTROSCOPY; MATRIX TABLET; TABLET COMPRESSION; TABLET FRIABILITY; TABLET HARDNESS; CHEMICAL MODEL; CHEMISTRY; DELAYED RELEASE FORMULATION; DIFFUSION; DRUG FORMULATION; GEL; HARDNESS; KINETICS; ORAL DRUG ADMINISTRATION; SOLUBILITY; TABLET;

ADMINISTRATION, ORAL; ADRENERGIC BETA-ANTAGONISTS; CHEMISTRY, PHARMACEUTICAL; DELAYED-ACTION PREPARATIONS; DIFFUSION; DRUG CARRIERS; DRUG COMPOUNDING; GALACTANS; GELS; HARDNESS; KINETICS; MANNANS; MODELS, CHEMICAL; PLANT GUMS; POLYSACCHARIDES, BACTERIAL; PROPRANOLOL; SOLUBILITY; STEARIC ACIDS; TABLETS; TALC;

EID: 65449150569     PISSN: 1011601X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Abrahamsson B, Alpsten M, Bake B, Jonsson UE, Larsson A, Lepkowaska ME (1998). Drug absorption from nifedipine hydrophilic matrix extended-release (ER) tablet compression with osmotic pump tablet and effect of food. J. Control Rel., 52(3): 301-310. (Pubitemid 28135258)
2. Abrahamsson B, Roos K and Sjogren J (1999). Investigation of prandial effect on hydrophilic matrix tablets. Drug Dev. Ind. Pharm., 25: 765-771. (Pubitemid 29239406)
3. Billa N and Yuen KH (2000). Formulation variables affecting drug release from xanthan gum matrices at laboratory scale and pilot scale. AAPS Pharma. Sci. Tech., 1(4): 1-8.
4. Bhardwaj TR, Kanwar M, Lad R and Gupta A (2000). Natural gums and modified natural gums as sustainedrelease carriers. Drug Dev. Ind. Pharm., 26(10): 1025-1038. (Pubitemid 30736906)
5. Bresolin TMB, Sander PC, Reicher F, Sierakowski MR Rinaudo M, Ganter JLMS (1997). Viscometric studies on xanthan and galactomannan systems. Carbohydr. Polym., 33: 131-138. (Pubitemid 127395261)
6. Bresolin TMB, Milas M, Rinaudo M, Reicher F and Ganter JLMS (1999). Role of galactomannan composition on the binary gel formation with xanthan. Int. J. Biol. Macromol., 26: 225-231. (Pubitemid 29494939)
7. Colombo P, Conte U, Caramella C, Gazzaniga A and La Manna A (1985). Compressed polymeric mini-matrices for drug release control. J. Control. Rel., 1: 283-289. (Pubitemid 15057115)
8. Cox PJ, Khan KA, Munday DL and Sujja-areevath J (1999). Development and evaluation of a multiple-unit release dosage form for S (+)-ibuprofen: preparation and release kinetics. Int. J. Pharm., 193: 73-84.
9. Dea ICM and Morrison A (1975). Chemistry and interactions of seed galactomannans. Adv. Carbohydrate Chemistry and Bbiochemistry. 31: 242-312.
10. Eddy CG, Antonio IC, Bernard B, Jose LP et.al (2006). Development and optimization of a novel sustainedrelease dextran tablet formulation for Propranolol hydrochloride. Int. J. Pharma., 317: 32-39.
11. Efentakis M and Loutlis A (2001). Release of furosemide from multiple-unit and single-unit preparations containing different viscosity grades of sodium alginate. Pharm. Dev. Technol., 6: 91-98.
12. Gai MN, Isla A, Andonaegui MT, Thielemann AM and Seitz C (1997). Evaluation of the effect of 3 different diets on the bioavailability of 2 sustained release theophylline matrix tablets. Int. J. Clin. Parmacol. Ther., 35(12): 565-571. (Pubitemid 28010385)
13. Harland RS, Gazzaniga A, Sanagalli ME, Colombo P and Peppas NA (1988). Drug/polymer matrix swelling and dissolution. Pharm. Res., 5(8): 488-494.
14. Haskell WL, Spiller GA, Jensen CD, Ellis BK and Gates JE (1992). Role of water-soluble dietary fiber in the management of elevated plasma cholesterol in healthy subjects. Am. J. Cardiol., 5(69): 433-439.
15. Hogan JE (1989). Hydroxypropylmethylcellulose sustained release technology. Drug Dev. Ind. Pharm., 15: 975-999.
16. Khullar P, Khar R and Agarwal SP (1998). Evaluation of guar gum in the preparation of sustained-release matrix tablets. Drug Dev. Ind. Pharm., 24(11): 1095-1099. (Pubitemid 28460250)
17. Korsmeyer RW and Peppas NA (1981). Macromolecular and modeling aspects of swelling-controlled systems. In: Roseman TS, Mansdorf SZ ed. Controlled Release Delivery Systems. Marcel Dekker. New York, pp.77-90.
18. Launay B, Doublier JR and Cuvelier G (1986). Flow properties of aqueous solutions and dispersions of polysaccharides. In: Mitchell JR, Ledward DA, ed. Functional properties of food macromolecules. Elsevier Applied Science. London, pp.1-78.
19. Lee PL and Kim CJ (1991). Probing the mechanism of drug release from hydrogels. J. Control. Rel., 16: 229-236.
20. Longxiao Liu and Binjie C (2006). Preparation of monolithic osmotic pump system by coating the indented core tablet. Eur. J. Pharma., 64: 180-184.
21. Morris ER (1990). Mixed polymer gels. In: Harris P ed. Food gels. Elsevier Applied Science. London, pp.291-360.
22. Morris VJ (1995). Bacterial polysaccharides, In: Food Polysaccharides and Their Applications. Marcel Dekker Inc., New York, pp.478-493.
23. Munday DL and Cox PJ (2000). Compressed xanthan and karaya gum matrices: hydration, erosion and drug release mechanisms. Int. J. Pharm., 203: 179-192.
24. Nürnberg E and Retting E (1974). On the characterisation of hydrocolloidal slow-release tablets illustrated for the example "Danaden® retard" tablets. Drugs Made. Germ., 17: 26.
25. Oosterhuis B and Jonkman JLH (1993). Pharmacokinetics studies in healthy volunteers in the context of in vitro/ in vivo correlations. Eur. J. Drug Metab. Pharmacokinetics. 18: 19-30.
26. Peppas NA and sahlin JJ (1989). A simple equation for the description of sustained release III Coupling of diffusion and relaxation. Int. J. Pharm., 57: 169-172.
27. Rekhi SG, Porter SC and Jambhekar SS (1996). Factors affecting the release of propranolol hydrochloride from beads coated with aqueous polymeric dispersion. Drug dev. Ind. Pham., 221: 709-729.
28. Ritger PL and Peppas NA (1987). A simple equation for description of solute release II Fickian and anomalous from swellable devices. J. Control. Rel., 5: 37-42.
29. Reynolds TD, Gehrke SH, Hussain AS and Shenouda LS (1998). Polymer erosion and drug release characterization of hydroxypropylmethylcellulose matrices. J. Pharm. Sci., 87(9): 1115-1123. (Pubitemid 28452113)
30. Staniforth JN and Baichwal AR (1993). Synergistically interacting heterodisperse polysaccharides. In polymer delivery systems, ACS Symposium Series; American Chemical Society. USA, 520: 327-350.
31. Sujja-areevath J, Munday DL, Cox PJ and Khan KA (1998). Relationship between swelling, erosion and drug release in hydrophilic natural gum mini-matrix formulations. Eur. J. Pharm. Sci., 6: 207-217.
32. Takayama K and Nagai T (1989). Novel computer optimization methodology for pharmaceutical formulations investigated by using sustained-release granules of indomethacin. Chem. Pharm. Bull., 37: 160-167.
33. Talukdar MM and Kinget R (1997). Comparative study on xanthan gum and hydroxypropyl methylcellulose as matrices for controlled-release drug delivery: II drug diffusion in hydrated matrices. Int. J. Pharm., 151: 99-107.
34. Talukdar MM, Van den Mooter G, Augustijns P, Tjandra- Maga T, Verbeke N, Kinget R (1998). In vitro evaluation of xanthan gum as a potential excipient for oral controlled-release matrix tablet formulation. Int. J. Pharm., 169: 105-113. (Pubitemid 28352603)
35. Toko M (1991). Synergistic interaction between deacetylated xanthan and galactomannan. J. Carbohydr., 10: 619-633.
36. Welling PG (1996). Effect of food on drug absorption. Annu. Rev. Nutri., 16: 383-415.